Iovance Biotherapeutics, based in Philadelphia, specializes in developing cutting-edge therapies for cancer treatment. Their focus lies in the research and development of investigational tumor infiltrating lymphocyte (TIL) therapy and peripheral blood lymphocyte (PBL) therapy.
With a strong emphasis on clinical trials and advancing their pipeline, Iovance Biotherapeutics is dedicated to pushing the boundaries of cancer treatment to improve patient outcomes and quality of life.
Generated from their website's infomation